Related Experiment Video
Updated: Jun 12, 2025

08:52
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
8.8K
Rapidly Progressive High-Grade Leiomyosarcoma in an Elderly Patient
Elias Uyar1, Sabrina Carpintieri2, Alberto Gomez Veliz3
1Internal Medicine, Ross University School of Medicine, Miami, USA.
Cureus
|September 27, 2024
Summary
This case study details a rapidly progressing high-grade leiomyosarcoma in an elderly patient. Aggressive tumor growth and early metastasis led to rapid clinical decline and hospice care, highlighting treatment challenges in frail individuals.
Area of Science:
- Oncology
- Surgical Pathology
- Geriatric Medicine
Background:
- High-grade leiomyosarcoma is a rare and aggressive soft tissue sarcoma.
- Elderly patients with comorbidities present unique challenges for cancer treatment.
Observation:
- An 84-year-old female presented with a rapidly enlarging proximal thigh mass diagnosed as high-grade leiomyosarcoma.
- The tumor demonstrated aggressive growth, doubling in size within two weeks.
- Post-operatively, the patient developed acute respiratory distress, pulmonary metastases, pulmonary embolism, and decompensated heart failure.
Findings:
- The patient experienced rapid clinical deterioration due to extensive metastatic leiomyosarcoma and complications.
- Neoadjuvant chemotherapy was precluded by patient frailty (cachexia).
- Despite anticoagulation and supportive care, the patient's status declined, leading to hospice care.
Implications:
- This case underscores the challenges of managing rapidly progressive sarcomas in frail elderly patients.
- Treatment decisions must carefully weigh potential benefits against toxicities in vulnerable populations.
- Multidisciplinary input is crucial for optimal patient selection for aggressive cancer therapies.
Keywords:
acute pulmonary embolismextraskeletal osteosarcomaheart failure with reduced ejection fractionleiomyosarcoma of the thighmetastatic lung nodule
